Active Ingredient: SODIUM PHENYLBUTYRATE; TAURURSODIOL
Proprietary Name: RELYVRIO
Dosage Form; Route of Administration: FOR SUSPENSION; ORAL
Strength: 3GM/PACKET; 1GM/PACKET
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N216660
Product Number: 001
Approval Date: Sep 29, 2022
Applicant Holder Full Name: AMYLYX PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
